Skip to main content

Ana Maria Ortiz de Urbina Olive

Institutions of which they are part

Research assistant
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Ana Maria Ortiz de Urbina Olive

Institutions of which they are part

Research assistant
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Projects

Individualización de la Monitorización continua de glucosa en la población anciana con diabetes mellitus tipo 2 en función del Estado cognitivo

IP: Monica Sanchez Bartres
Collaborators: Angel Michael Ortiz Zúñiga, Ana Maria Ortiz de Urbina Olive, Individualización de la Monitorización continua de glucosa en la población anciana con diabetes mellitus tipo 2 en función del E, Mercè Abad Martín, Olga Simó Servat, Pedro Alejandro Gil Millán
Funding agency: Sociedad Española de Diabetes
Funding: 20000
Reference: SED/SANCHEZ/2023
Duration: 01/12/2023 - 31/05/2025

Diabetis i metabolisme

IP: Rafael Simó Canonge
Collaborators: Josep A Villena Delgado, Carles Zafon Llopis, Cristina Hernández Pascual, David Martinez Selva, Rosario Pardo Diaz, Angel Michael Ortiz Zúñiga, Andreea Ciudin Mihai, Fiorella Ximena Palmas Candia, Ana Maria Ortiz de Urbina Olive, Monica Sanchez Bartres, Lorena Ramos Pérez, Marc Rivas Agudo, Diabetis i metabolisme, Anna Casteras Román, Alejandra Planas Vilaseca, Betina Biagetti Biagetti, Diabetis i metabolisme, Mercè Abad Martín, Marta Comas Martinez, Hugo Ramos Abellan, Rosa Burgos Peláez, David Sabater Martínez, Olga Simó Servat, Patricia Bogdanov Baruj, Maria Llorian Salvador, Enzamaría Fidilio Meli
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00655
Duration: 01/01/2022 - 30/06/2025

Related news

The publications update the pharmacological management guideline for obesity and its complications and present the first European comprehensive management guideline for patients with obesity treated with medications.

The study evaluates elecoglipron and shows improvements in glycemic control and body weight compared with placebo.

The study is expected to contribute to the identification of new therapeutic targets and the development of nutritional strategies to improve health.

Related professionals

Victor Franco Puntes

Victor Franco Puntes

Head of group
Pharmacokinetic Nanoparticles
Read more
Francisco Javier Medel Rebollo

Francisco Javier Medel Rebollo

Main researcher
Clinical Pharmacology
Read more
Anna Santamaria Margalef

Anna Santamaria Margalef

Director/a Àrea
Internal Strategy Directorate
Read more
Vanessa Bueno López

Vanessa Bueno López

Senior researcher
Maternal and Fetal Medicine
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.